Novo Nordisk A/S, which faces higher demand for its diabetes and weight-loss drugs than it can meet, signed a long-term agreement with Ypsomed Holding AG for the supply of auto-injectors. Ypsomed is ...
Ypsomed has purchased a 160,000 square-foot facility in Holly Springs, N.C., investing $248 million in its "first phase" of construction of the site. It will be the Swiss company's first outlet in the ...
Sept 20 (Reuters) - Swiss medical technology company Ypsomed YPSN.S announced on Wednesday a long-term supply deal with Novo Nordisk NOVOb.CO for autoinjectors, the latest sign of how the Danish ...
During a transition period expected to last through mid-2025, Ypsomed will serve as a contract manufacturer to maintain the supply of insulin pen needles while its production equipment is gradually ...
Lannett has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the pen injector device to be used in connection with its biosimilar insulin glargine and biosimilar insulin ...
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare ...
Earnings call Ypsomed reported CHF 267M in core delivery systems revenue for H1 FY25/26, growing 21% YoY, with EBIT of CHF 87M and a 32.4% margin. Management reaffirmed FY guidance for ~20% revenue ...
LONDON, Nov 22 (Reuters) - Swiss medical technology company Ypsomed's (YPSN.S), opens new tab contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's ...
Good morning. Welcome, everyone, to Ypsomed Half Year Results 2025-2026 Earnings Conference call. Today, with CEO, Simon Michel; and CFO, Samuel Kunzli, we would like to go over our first half year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results